Science
B.C. particle accelerator scores triumph with deal to produce ‘rarest drug on earth’ – q107.com
UBC’s TRIUMF facility is gearing up to produce actinium-225, a rare radioisotope that early research shows could have a powerful effect fighting cancer.
A team at the Canada’s particle accelerator facility at the University of British Columbia is celebrating a major triumph, inking a deal to produce a rare cancer drug that previously relied on nuclear waste.
The TRIUMF project has formed a partnership with Ontario-based Fusion Pharmaceuticals to upgrade its facility to produce actinium-225, nicknamed “the rarest drug on Earth.”
Read more: BWXT Peterborough touts ‘tremendous progress’ in medical isotope production at Darlington nuclear station
That…
-
General23 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
Noosa News23 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General17 hours agoTribute unveiled for SA Police Brevet Sergeant Jason Doig after fatal 2023 shooting
-
Noosa News3 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred